• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Most Common Treatment for Prostate Cancer Not Best Value

Article

External beam radiation is the most toxic and expensive among common prostate cancer treatments over the long-term, a national registry study suggested.

Although it's one of the most common treatments for Medicare patients with prostate cancer, external beam radiation had the highest 16-year cumulative risk of serious gastrointestinal and genitourinary problems compared with surgery and brachytherapy, Jay Ciezki, MD, of the Cleveland Clinic, and colleagues found.

External beam radiation also cost twice as much as either of the other treatments when adding up initial treatment plus management of complications, he reported at a press briefing ahead of presentation at the Genitourinary Cancers Symposium here.

The average cost per patient-year was $6,412 with external radiation versus $3,206 with open prostatectomy and $2,557 for brachytherapy (P<0.0001).

Read more about this study at: http://tinyurl.com/83qzpsx

Source: MedPage Today

Related Videos
Philip Mease, MD
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Dr Eric Yang
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Eric Yang
Eleanor Perfetto, PhD
Tom Kim, chief medical officer, Sound Long-Term Care Management
Drs Yelena Janjigian and Zev Wainberg | Background image credit: ipopba - stock.adobe.com
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.